SMARCB1 and neoplasm: Therefore, they should be classified as SMARCB1 deficient medullary RCC, a highly aggressive tumor in young patients with a sickle cell trait (with hypoxia of papillae caused by this condition possibly linked to tumorigenesis) [42].